Your browser doesn't support javascript.
loading
Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the Literature.
Abdayem, Pamela; Ghosn, Marwan; Valero, Vicente; Walters, Ronald; Arun, Banu; Murray, James L; Theriault, Richard; Frye, Debbie; Ibrahim, Nuhad K.
Afiliação
  • Abdayem P; 1. Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.
  • Ghosn M; 2. Professor, Chairman of the department of Hematology and Medical Oncology at Saint-Joseph University Faculty of Medicine, Beirut, Lebanon.
  • Valero V; 3. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, TX, USA.
  • Walters R; 3. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, TX, USA.
  • Arun B; 3. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, TX, USA.
  • Murray JL; 3. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, TX, USA.
  • Theriault R; 3. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, TX, USA.
  • Frye D; 3. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, TX, USA.
  • Ibrahim NK; 3. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, TX, USA.
J Cancer ; 5(5): 351-9, 2014.
Article em En | MEDLINE | ID: mdl-24723978

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article